{"id":"W2774947310","doi":"10.3899/jrheum.170487","title":"Safety and Efficacy of Golimumab Administered Intravenously in Adults with Ankylosing Spondylitis: Results through Week 28 of the GO-ALIVE Study","year":2017,"lang":"en","type":"article","venue":"The Journal of Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Scientific Affairs","keywords":"Medicine; Ankylosing spondylitis; BASFI; Golimumab; Placebo; Internal medicine; Clinical endpoint; Spondylitis; Adverse effect; Randomization; Crossover study; Randomized controlled trial; BASDAI; Gastroenterology; Adalimumab; Disease","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001740587,0.0006462495,0.001647235,0.0001985684,0.0003111312,0.000537259,0.0004373557,0.001035345,0.001332198],"category_scores_gemma":[0.001536797,0.0002369613,0.0009500373,0.0002037234,0.0003743098,0.0004867604,0.0003033853,0.001285509,0.0004134056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002889231,"about_ca_system_score_gemma":0.0005687699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004092408,"about_ca_topic_score_gemma":0.0006940776,"domain_scores_codex":[0.999469,0.0002716923,0.00003873763,0.00008006181,0.00007089898,0.00006962594],"domain_scores_gemma":[0.9989397,0.0001862936,0.0004025795,0.00007753276,0.00008800112,0.0003058694],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8621909,0.01073881,0.0361261,0.0008474636,0.001991871,0.0001684392,0.0001956342,0.0006609448,0.01271152,0.00008797779,0.001740193,0.07254012],"study_design_scores_gemma":[0.5347222,0.2998313,0.1564296,0.0001769127,0.002508871,0.0002985666,0.00009054162,0.0006740213,0.002143675,0.0001417199,0.002940527,0.00004212669],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945613,0.003579884,0.0001673407,0.0002485435,0.00003876514,0.0003017292,0.0005786473,0.00002978938,0.0004940308],"genre_scores_gemma":[0.9963213,0.00112667,0.0003686807,0.0003965751,0.00009685192,0.0003397054,0.0007967685,0.000008464482,0.0005449204],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001740587,"threshold_uncertainty_score":0.009205222,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02005610838217822,"score_gpt":0.284980756876653,"score_spread":0.2649246484944748,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}